Literature DB >> 8976251

Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated.

M K Terris1, T Q Pham, M M Issa, J N Kabalin.   

Abstract

PURPOSE: Transrectal ultrasound guided biopsies of the transition zone and seminal vesicles have been useful in select patients. More widespread use of these additional biopsies has been proposed. The efficacy of routine transition zone and seminal vesicle biopsies was examined.
MATERIALS AND METHODS: From January 1988 to October 1994, 736 transrectal ultrasound guided systematic sextant biopsies were performed. From October 1994 to July 1995, 161 consecutive patients underwent transrectal ultrasound with systematic sextant, transition zone and seminal vesicle biopsies.
RESULTS: Of the 736 patients undergoing only sextant biopsies 309 (42.0%) had cancer and 24 (3.3%) required repeat biopsy, compared to 55 (34.2%) and 4 (2.5%) of 161 undergoing combined sextant, transition zone and seminal vesicle biopsies. Prostate cancer was found only in the systematic sextant biopsies in 43 of the former 55 patients (78.2%), and in the transition zone and systematic sextant biopsies in 11 (20.0%). One patient (1.8% of patients with cancer or 0.6% of all 161 patients) had cancer in only the anterior biopsies and 6 (10.9 and 3.7%, respectively) had cancer involving the seminal vesicles.
CONCLUSIONS: Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided systematic sextant biopsies are not warranted.

Entities:  

Mesh:

Year:  1997        PMID: 8976251

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

1.  Prostate cancer: The optimal number and location of cores for repeat biopsy.

Authors:  J Stephen Jones
Journal:  Nat Rev Urol       Date:  2011-10-25       Impact factor: 14.432

2.  CUA guidelines on prostate biopsy methodology.

Authors:  Assaad El-Hakim; Sabri Moussa
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

3.  Prostate biopsy: targeting cancer for detection and therapy.

Authors:  Samir S Taneja
Journal:  Rev Urol       Date:  2006

4.  Optimizing prostate biopsy strategies for the diagnosis of prostate cancer.

Authors:  Samir S Taneja
Journal:  Rev Urol       Date:  2003

Review 5.  Biopsy standards for detection of prostate cancer.

Authors:  Bob Djavan; Markus Margreiter
Journal:  World J Urol       Date:  2007-03-07       Impact factor: 4.226

Review 6.  Management of rising prostate-specific antigen after a negative biopsy.

Authors:  David A Levy; J Stephen Jones
Journal:  Curr Urol Rep       Date:  2011-06       Impact factor: 3.092

Review 7.  Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.

Authors:  Marc A Bjurlin; H Ballentine Carter; Paul Schellhammer; Michael S Cookson; Leonard G Gomella; Dean Troyer; Thomas M Wheeler; Steven Schlossberg; David F Penson; Samir S Taneja
Journal:  J Urol       Date:  2013-02-26       Impact factor: 7.450

8.  Do prostatic transition zone tumors have a distinct morphology?

Authors:  Joaquin J Garcia; Hikmat A Al-Ahmadie; Anuradha Gopalan; Satish K Tickoo; Peter T Scardino; Victor E Reuter; Samson W Fine
Journal:  Am J Surg Pathol       Date:  2008-11       Impact factor: 6.394

Review 9.  [Transrectal ultrasound-guided punch biopsies of the prostate. Indication, technique, results, and complications].

Authors:  J Palisaar; T Eggert; M Graefen; A Haese; H Huland
Journal:  Urologe A       Date:  2003-09       Impact factor: 0.639

Review 10.  A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies.

Authors:  Koenraad van Renterghem; Gommert Van Koeveringe; Ruth Achten; Philip van Kerrebroeck
Journal:  Int Urol Nephrol       Date:  2009-06-03       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.